Literature DB >> 28297678

Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glucose Intolerance.

Yasutaka Miyachi1, Kyoichiro Tsuchiya2, Chikara Komiya1, Kumiko Shiba1, Noriko Shimazu1, Shinobu Yamaguchi1, Michiyo Deushi3, Mizuko Osaka3, Kouji Inoue4, Yuta Sato5, Sayaka Matsumoto5, Junichi Kikuta5, Kenjiro Wake4, Masayuki Yoshida3, Masaru Ishii5, Yoshihiro Ogawa6.   

Abstract

Obesity promotes infiltration of inflammatory cells into various tissues, leading to parenchymal and stromal cell interaction and development of cellular and organ dysfunction. Liver sinusoidal endothelial cells (LSECs) are the first cells that contact portal blood cells and substances in the liver, but their functions in the development of obesity-associated glucose metabolism remain unclear. Here, we find that LSECs are involved in obesity-associated accumulation of myeloid cells via VLA-4-dependent cell-cell adhesion. VLA-4 blockade in mice fed a high-fat diet attenuated myeloid cell accumulation in the liver to improve hepatic inflammation and systemic glucose intolerance. Ex vivo studies further show that cell-cell contact between intrahepatic leukocytes and parenchymal hepatocytes induces gluconeogenesis via a Notch-dependent pathway. These findings suggest that cell-cell interaction between parenchymal and stromal cells regulates hepatic glucose metabolism and offers potential strategies for treatment or prevention of obesity-associated glucose intolerance.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Notch signaling; diabetes; inflammation; insulin resistance; liver sinusoidal endothelial cells; macrophages; monocytes; neutrophils; obesity

Mesh:

Substances:

Year:  2017        PMID: 28297678     DOI: 10.1016/j.celrep.2017.02.039

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis.

Authors:  Kunimaro Furuta; Qianqian Guo; Kevin D Pavelko; Jeong-Heon Lee; Keith D Robertson; Yasuhiko Nakao; Jan Melek; Vijay H Shah; Petra Hirsova; Samar H Ibrahim
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 2.  The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.

Authors:  Wei Du; Lin Wang
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

Review 3.  Macrophage functional diversity in NAFLD - more than inflammation.

Authors:  Emelie Barreby; Ping Chen; Myriam Aouadi
Journal:  Nat Rev Endocrinol       Date:  2022-05-09       Impact factor: 47.564

Review 4.  UCP1 governs liver extracellular succinate and inflammatory pathogenesis.

Authors:  Evanna L Mills; Cathal Harmon; Mark P Jedrychowski; Haopeng Xiao; Ryan Garrity; Nhien V Tran; Gary A Bradshaw; Accalia Fu; John Szpyt; Anita Reddy; Hannah Prendeville; Nika N Danial; Steven P Gygi; Lydia Lynch; Edward T Chouchani
Journal:  Nat Metab       Date:  2021-05-17

5.  Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.

Authors:  Yusuke Sasaki; Masato Asahiyama; Toshiya Tanaka; Shogo Yamamoto; Kentaro Murakami; Wakana Kamiya; Yoshihiro Matsumura; Tsuyoshi Osawa; Motonobu Anai; Jean-Charles Fruchart; Hiroyuki Aburatani; Juro Sakai; Tatsuhiko Kodama
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

Review 6.  The Role of Myeloid-Derived Cells in the Progression of Liver Disease.

Authors:  Chris John Weston; Henning Wolfgang Zimmermann; David H Adams
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

Review 7.  Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.

Authors:  Haiou Li; Yunjiao Zhou; Haizhou Wang; Meng Zhang; Peishan Qiu; Mengna Zhang; Ruike Zhang; Qiu Zhao; Jing Liu
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

8.  A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition.

Authors:  Yasutaka Miyachi; Kyoichiro Tsuchiya; Kumiko Shiba; Kentaro Mori; Chikara Komiya; Naomi Ogasawara; Yoshihiro Ogawa
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

Review 9.  Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Kia M Peters; Rachel B Wilson; Nica M Borradaile
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

Review 10.  Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.

Authors:  Sander Lefere; Frank Tacke
Journal:  JHEP Rep       Date:  2019-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.